UK Health Security Agency

Answers to frequently raised questions relating to the national gonorrhoea vaccination programme using 4CMenB vaccine.

UK Health Security Agency's immunoglobulin handbook, providing guidance on administering immunoglobulin to prevent serious disease.

The UK Malaria Expert Advisory Group (formerly the Advisory Committee on Malaria Prevention) updates and reissues these guidelines every year for UK travellers.

Monthly data and commentary on coverage achieved by the UK childhood vaccination programme in England.

Quarterly reports, with commentary, on cases confirmed by UK Health Security Agency's Virus Reference Department or local laboratory testing.

National influenza (flu) and COVID-19 report, monitoring COVID-19 activity, seasonal flu and other seasonal respiratory illnesses.

The number of people contacting their GPs outside of surgery hours under the syndromic surveillance system.

This weekly summary highlights changes in the number of people visiting GPs, going to emergency departments and calling NHS 111.

A national public health bulletin from the UK Health Security Agency (UKHSA).

How to manage cases of suspected measles: what patient details to take, who to notify and assessing risk of disease spreading in close contacts.

The national surveillance scheme has a reporting form for Legionnaires' disease in England and Wales.

Vaccine uptake data and commentary about the pertussis (whooping cough) vaccination programme for pregnant women.

The latest quarterly reports of provisional data for tuberculosis (TB) notifications in England.

Reports of norovirus and rotavirus laboratory surveillance and enteric virus outbreaks in hospital settings in England during the 2026 to 2027 season.

The number of people calling ambulances each day, with results published every week under the syndromic surveillance system.

A national partnership agreement on meeting the health and wellbeing needs for people seeking asylum in England from 2025 to 2028.

Laboratory reports on cases of Haemophilus influenzae in England.

How the actual number of deaths in England compare with the expected numbers of deaths for each week.

Information on respiratory syncytial virus (RSV) and the benefits of vaccination for adults and resources to promote the vaccination to older adults.

Data on the latest findings relating to antimicrobial resistance in Mycoplasma genitalium from specimens collected in sexual health clinics across England.

Summary of the number of people calling NHS 111 for health advice within England on a weekly basis under the syndromic surveillance system.

National influenza (flu) and COVID-19 report, monitoring COVID-19 activity, seasonal flu and other seasonal respiratory illnesses.

Monitors the number of people who visit their GP during surgery hours under the syndromic surveillance system.

Air quality reports for the survivors and residents of the area surrounding Grenfell Tower.

The number of people going to emergency departments each day, with results published every week under the syndromic surveillance system.

Latest information on global disease events under monitoring.

Ad-hoc statistics report on the surveillance of mortality during the May and June 2026 heat episodes in England.

Lists of those receiving pre-release access to UK Health Security Agency Tuberculosis in England: national quarterly reports.

Official statistics from the UK enhanced tuberculosis surveillance systems, annual report: 2000 to 2025.

Official statistics from the UK enhanced tuberculosis surveillance systems, annual report: 2000 to 2024.

Lists of those receiving pre-release access to UK Health Security Agency Tuberculosis annual data

Vaccine group direction (VGD) template to support the national vaccination programme for pregnant women to protect infants and selected older adults as outlined in the RSV system letter.

Patient group direction (PGD) template to support the national vaccination programme for pregnant women to protect infants and selected older adults as outlined in the RSV system letter.

Weekly data from UK laboratories on the number of cases of notifiable bacteria and viruses (see important note in Details section, below).

Identification and management of outbreaks and resources to support local health protection system response to outbreaks of communicable disease.

Details of UK Health Security Agency (UKHSA) transactions over £25,000 in 2026.

Easy read information on the MMRV vaccination which protects against measles, mumps, rubella and varicella.

Information for healthcare professionals on the diagnosis and treatment of infant botulism, foodborne botulism and wound botulism.

Guidance for health professionals delivering the time-limited MenB vaccination offer on the eligible cohort.

The number of infections of Shiga-toxin producing Escherichia coli (STEC) reported in England and Wales for 2019 and 2020, and England only from 2021 onwards.

Number of laboratory-confirmed cases of measles in England.

Details of UK Health Security Agency (UKHSA) Government Procurement Card (GPC) transactions over £500.

Data showing the seasonality of major respiratory viruses.

A guide to UKHSA's bacteriology reference department (BRD), its units and the tests and services it provides.

How to label, package and submit specimens to the laboratory for diagnostic testing.

Influenza vaccines marketed in the UK for 2026 to 2027, including ovalbumin content.

Information on how to stay safe in hot weather, including how to keep your home cool.

A quick reference guide to the childhood flu vaccines for winter 2026 to 2027.

Guidance for health professionals delivering the time-limited MenB vaccination offer for year 13 age group for academic year 2025 to 2026 and eligible higher and further education entrants under 25 years for 2026 to 2027.

Template for GPs to invite patients at risk of flu due to a medical condition or age, and their carers, to have their annual flu vaccine.

Cumulative weekly data on invasive pneumococcal disease (IPD) infections due to serotypes not in Prevenar 13™ vaccine.

Cumulative weekly data on invasive pneumococcal disease (IPD) infections due to serotypes in Prevenar 13™ in England.

Guidance on managing risk of bloodborne viruses (BBVs), such as hepatitis B, hepatitis C and HIV, in bomb blast victims.

Information on the FluSurvey surveillance system data.

This guidance supports risk assessment, investigation and management of infection control breaches, with a focus on BBV transmission.

The Pathogen Genomics Department at Porton Down provides a sequencing service for SARS-CoV-2 for customers across the NHS and UKHSA.

Describes the working relationship between the Department of Health and Social Care and the UK Health Security Agency.

Incidence, treatment and prevention of tuberculosis (TB) in England using data up until the end of 2024.

Epidemiological data on Zika virus disease cases in England, Wales and Northern Ireland.

Epidemiological data on typhoid and paratyphoid cases in England, Wales and Northern Ireland.

Epidemiological data for imported malaria in the UK.

Epidemiological data on chikungunya cases in England, Wales and Northern Ireland.

Epidemiological data on laboratory-confirmed dengue cases in England, Wales and Northern Ireland.

Information on the inclusion of people experiencing homelessness (PEH) as a new clinical risk group eligible for pneumococcal vaccination from 1 October 2026.

Information on the Meningococcal B (MenB) time limited vaccination offer.

Reports presenting annual epidemiological data for HIV in Yorkshire and Humber.

Reported cases of tetanus in England.

A rapid systematic review on hand hygiene alternatives to soap and water for reducing C. difficile.

A practical guide for staff on managing cases of infectious diseases in children and young people's settings, including education.

The Virus Reference Department (VRD) provides clinical advice and investigations for a wide range of human virus infections.

How to classify and manage people who have been exposed to CCHF.

How the actual number of deaths in England compare with the expected numbers of deaths for each week.

The latest information on mpox clade Ib and clade IIb cases in the UK and mpox vaccine administration in England.

Trends in meticillin resistant (MRSA) and meticillin susceptible (MSSA) Staphylococcus aureus, Gram-negative bacteraemia and Clostridioides difficile infection.

How to classify and manage people who have been exposed to Ebola disease or Marburg virus disease.

UKHSA and Porton Biopharma Limited have committed to being more transparent with the public about when, how and why we use animals in research.

Laboratory-confirmed cases and notifications of measles in England. Deaths apply to England and Wales.

Quarterly reports on acquired carbapenemase-producing Gram-negative organisms (CPOs) identified in human samples in England.

Data submission deadlines and publication dates for the COVER programme.

List of available tests for meningococcal disease, what specimens to send and turnaround times.

Annual data of reported Campylobacter infections in England since 2006.

Information for health professionals on the rotavirus vaccination programme.

Information on the Global Polio Eradication programme, UK National Authority for Containment (NAC) and environmental surveillance for polio.

Tables showing confirmed toxigenic C. diphtheriae cases among asylum seekers in England between 2022 and 2026.

Official statistics data and reporting on vaccine uptake for the RSV (respiratory syncytial virus) vaccination programme for pregnant women.

Information for clinicians and referring laboratories about the range of tests offered by the Rare and Imported Pathogens Laboratory (RIPL).

Reports of norovirus and rotavirus laboratory surveillance and enteric virus outbreaks in hospital settings in England during the 2025 to 2026 season.

Vaccine uptake data for the respiratory syncytial virus (RSV) vaccination programme for older adults.

Lists of those receiving pre-release access to UK Health Security Agency national norovirus and rotavirus surveillance reports

Reports presenting data since 2014 for sexually transmitted infections (STIs) in London.

Policy to report incidents during delivery of chlamydia screening to the UK Health Security Agency (UKHSA).

MRSA, MSSA, Gram-negative bacteraemia infections by organisation and location of onset, and Clostridioides difficile infections (CDI) by organisation and prior trust exposure.

Information on the expansion of the eligibility criteria of the older adults respiratory syncytial virus (RSV) vaccination programme from 1 September 2026.

List of those receiving pre-release access to the monthly UK Health Security Agency mandatory healthcare-associated infections (HCAI) statistical release.

This Evaluation Strategy sets out UKHSA’s organisation‑wide approach to planning, conducting and using evaluation across science, operations and public health policy.

This guidance provides the sources of Shiga toxin-producing Escherichia coli (STEC) infection and guidance on preventing infection.

UK quarterly data and commentary on coverage achieved by the UK childhood immunisation programme.

Trends in ribotypes of Clostridioides difficile (C. difficile) and research into the increased frequency of C. difficile infections (CDI).

Guidance on the delivery of antenatal screening and selective neonatal immunisation services for pregnant women living with hepatitis B and their babies.

Annual reports on voluntary surveillance of fungaemia (blood infections due to yeast species) in England.

These reports summarise trends in the epidemiology of COVID-19 in England. Reports will be published approximately every 6 months

Laboratory confirmed cases of pertussis reported to the enhanced pertussis surveillance programme in England.

Surveillance data relating to gastrointestinal pathogens.

Laboratory-confirmed cases of invasive meningococcal disease reported to the enhanced meningococcal surveillance programme in England.

Patient group direction (PGD) template to support the national meningococcal group B (Bexsero®) vaccination one-off, time-limited offer Autumn 2026 programme.

Interim update to the guidance on the most effective methods of prevention and control of Clostridioides difficile infection. This guidance is currently under review.

Information on the spring 2026 campaign for eligible individuals.

This privacy notice explains the personal information we collect, how we use it and who we may share it with.

The UKHSA public health laboratory in Birmingham provides a range of public health microbiology services to NHS trusts and health protection teams.

Joint Statement from OPSS, UKHSA and HSE.

Guidance for managing neonates of mothers with possible Zika virus exposure.

VGD template for administering inactivated influenza vaccine or live attenuated influenza vaccine in line, with the national seasonal flu vaccination programme.

PGD template for administering inactivated influenza vaccine or live attenuated influenza vaccine, in line with the national seasonal flu vaccination programme.

Report presenting annual epidemiological data for Human Immunodeficiency Virus (HIV) in East Midlands.

Report presenting annual epidemiological data for HIV in the West Midlands.

Resources for World Antimicrobial Resistance Awareness Week (WAAW) and European Antibiotic Awareness Day (EAAD) for healthcare professionals in England.

Evidence of the protective efficacy of vaccines for hantavirus in people or animals exposed to Andes virus.

The register helps inform the natural history of hepatitis C virus (HCV) infection in the UK with patient data.

Human-to-human hantavirus transmission: incubation, infectious period, asymptomatic or presymptomatic transmission and transmission routes.

The HSRA is UKHSA’s assessment characterising a selection of the most significant health security risks facing the UK over the next 5 years.

Reports presenting annual epidemiological data for HIV in north-west England.

This small and medium-sized enterprises (SME) action plan sets out how we will enable SMEs to play their full part in the delivery of UKHSA’s mission and priorities.

Reports presenting annual epidemiological data for HIV in London.

A toolkit to support local and regional stakeholders to understand and act on immunisation inequities in the populations they serve.

The annual flu letter describes the national flu immunisation programme and outlines which groups are eligible for flu vaccination.

An algorithm for midwives to help diagnose carbon monoxide poisoning in pregnant women and offer advice for pregnant women in the event of exposure.

One-page summary for health professionals and immunisation practitioners giving vaccinations.

Sources of data for the surveillance systems used to monitor COVID-19, influenza and other seasonal respiratory viruses in England.

Information on the adolescent vaccination programme delivered in secondary schools and the role that schools play.

The latest quarterly reports of provisional data for syphilis and gonorrhoea diagnoses in England.

Employers provide records of employment episodes, occupational exposure to ionising radiation and some personal identifying data.

Flu vaccination guidance and resources for schools.

Reports presenting data since 2020 for sexually transmitted infections (STIs) in the South East of England.

Historic reports stored on the National Archive.

Information about the meningococcal B (MenB) vaccine and paracetamol use.

An evidence-based framework to inform local prioritisation decisions for sexually transmitted infection (STI) control.

Respiratory syncytial virus immunisation information for public health professionals, including updates.

This guidance is for health practitioners implementing the vaccination programme to protect pregnant women and older adults from RSV.

Information on chlamydia testing and diagnoses in people aged 15 to 24 years in England.

Data up to 2025 on acute flaccid paralysis and myelitis in England (AFP/M).

Information on STI diagnoses and sexual health services provided in England.

Lists of those receiving pre-release access to the annual UKHSA sexually transmitted infections (STIs) and the National Chlamydia Screening Programme (NCSP) statistical releases.

Guidance for healthcare professionals on the public health management of pertussis (whooping cough).

Analysis and learning from radiotherapy and near miss data reported voluntarily by UK radiotherapy providers and the relevant reporting authorities.

A yearly overview of influenza surveillance results from the winter period.

Annual data from 2008 onwards for England.

Group A streptococcal infections: reports on seasonal activity in England, 2025 to 2026

Annual data of reported Cryptosporidium infections in England since 2014.

List of those receiving pre-release access to the 3 influenza vaccine uptake reports published by UKHSA.

Report on the uptake of influenza vaccine in GP patients during the 2025 to 2026 influenza vaccination programme in England.

Uptake of the seasonal influenza vaccine in frontline healthcare workers during the 2023 to 2024 influenza vaccination programme in England.

UKHSA publishes overviews each year of influenza surveillance results from the winter period.

Annual data of reported Listeria monocytogenes infections in England and Wales.

Evaluation of the Shingrix® herpes zoster (shingles) vaccination programme in England: academic years 2023/24, 2024/25 and 2025/26.

Overview of a national plan to track progress towards the intended impacts of the STI (sexually transmitted infections) Prioritisation Framework, preventing harm and reducing health inequalities

Report on the uptake of influenza vaccine in children of school age during the 2024 to 2025 influenza vaccination programme in England.

Uptake of the seasonal influenza vaccine in frontline healthcare workers during the 2024 to 2025 influenza vaccination programme in England.

Report on the uptake of influenza vaccine in children of school age during the 2025 to 2026 influenza vaccination programme in England.

Report on the uptake of influenza vaccine in frontline healthcare workers during the 2025 to 2026 influenza vaccination programme in England.

Report on the uptake of influenza vaccine in GP patients during the 2024 to 2025 influenza vaccination programme in England.

Statistical release in response to cases of hantavirus in the UK connected to the outbreak on the MV Hondius cruise ship.

This One Health vector-borne disease (VBD) surveillance report integrates data from vector, animal and human surveillance for 2025 in England

The latest annual reports of provisional data for new HIV diagnoses in England.

This strategy outlines UKHSA’s ambition and priority deliverables for the next 3 years to protect people from current and future health threats.

Safety advice on electric and magnetic fields in our homes and near power lines.

Guidelines on exposure to radio signals from smart meters.

Guidelines on reducing exposure to radio waves coming from mobile phones.

The history of Ebola virus disease, animal reservoirs, routes of transmission and an overview of diagnosis and management.

Guidance on reducing the risk of getting MERS-CoV for UK residents and travellers to the Middle East.

Guidance on public exposure to electromagnetic fields.

Infographic with advice on Middle East respiratory syndrome coronavirus (MERS-CoV) for people travelling to the UK from the Middle East.

Qualitative assessment of the risk to the UK human population of Andes virus infection in a UK rodent.

This privacy notice explains the personal information we collect on individuals as part of SSBBV testing, how we use it and who we may share it with.

Reports presenting hepatitis B virus surveillance information in different regions of England, with data to the end of 2024.

Public health analysis of progress towards meeting the aims of the HIV Action Plan for England.

Influenza immunisation information including updates for public health professionals.

The ESPAUR report includes national data on antimicrobial prescribing and resistance, antimicrobial stewardship implementation and awareness activities.

Technical briefing documents on the Invasive Meningococcal Disease outbreak 2026.

Patient group direction (PGD) template to support the provision of MMR vaccine to individuals with a date of birth on or after 1 January 2020.

Epidemic intelligence activities are undertaken to detect and assess potential emerging infectious disease threats to the UK.

Lists of those receiving pre-release access to UK Health Security Agency 'National flu and COVID-19 surveillance' reports.

Lists of those receiving pre-release access to the UK Health Security Agency 'Respiratory syncytial virus (RSV) maternal vaccination coverage' and 'Respiratory syncytial virus (RSV) older adults vaccination coverage' reports.

Monitoring and evaluation of doxycycline post-exposure prophylaxis (doxyPEP) in England to protect people at high risk of syphilis.

Quarterly reports, with commentary, on cases confirmed by UK Health Security Agency's Virus Reference Department or local laboratory testing.

Guidance for public health professionals to manage scabies cases and outbreaks, including recommendations for diagnosis, treatment and wider control measures.

Resources and information relating to the UKHSA's investigation of meningococcal bacteria carriage amongst students aged 18 to 24 in Kent taking place from May 2026.

Advice on staying well in cold weather, covering issues such as financial help, healthy lifestyle, flu vaccinations and heating.

A resource for clinicians to give to their patients.

Reports presenting data for sexually transmitted infections (STIs) in the West Midlands.

Reports presenting data since 2020 for sexually transmitted infections (STIs) in the East Midlands.

Weather-health alerts are issued by UKHSA in partnership with the Met Office.

The Adverse Weather and Health Plan aims to protect individuals and communities from the health effects of adverse weather and to build community resilience.

Guidance for custodial and healthcare teams in secure settings, NHS tuberculosis (TB) services and UK Health Security Agency (UKHSA) health protection teams.

Rapid evidence summary identifying evidence on the effectiveness of interventions to reduce gonorrhoea in heterosexual adolescents and young adults, aged 15 to 25 years, from peer-reviewed literature.

Details of the UK Health Security Agency's nationwide mosquito surveillance survey.

HIV surveillance data in the UK by demographic characteristics and geographical region.

Measles immunisation information for public health professionals, including updates.

Mumps immunisation information for public health professionals, including updates.

Rubella immunisation information for public health professionals, including updates.

Varicella immunisation information for public health professionals, including updates.

Qualitative assessment of the risk that Zika virus presents to the UK population.

Anonymised summaries of the use of statutory Part 2A orders to protect public health for the financial years from 2017 to 2018 up to 2024 to 2025.

Information for healthcare practitioners on delivering the pneumococcal vaccination programme for older adults and individuals in a clinical risk group.

List of those receiving pre-release access to the quarterly UK Health Security Agency mandatory healthcare associated infections (HCAI) statistical release.

Annual data of reported Giardia infections in England and Wales since 2007.

Statistical release in response to cases of invasive meningococcal disease in the UK.

How to classify and manage people who have been exposed to NiV.

Latest UK Health Security Agency hepatitis C virus reports and supporting documents, for England and the UK.

Core principles relating to the biology and transmission of Nipah virus.

When to suspect Nipah virus (NiV) infection.

Outlines the quality and methodology information (QMI) relevant to the heat mortality monitoring reports.

2025 report on the surveillance of mortality during heat episodes.

Lists of those receiving pre-release access to UK Health Security Agency heat mortality monitoring reports.

2024 annual report on the surveillance of mortality during heat episodes.

Information about routes of Zika virus transmission and ways to prevent this.

Information for public health professionals on immunisation.

Guidance on how to advise individual travellers on the duration of preventative measures against sexual transmission of Zika virus.

Flowchart for assessing women who have travelled while pregnant to areas with active Zika virus transmission.

This guidance delivers on the government’s commitment in response to the Coroner’s 'prevention of future deaths' report on the death of 2-year-old Awaab Ishak due to mould in the home.

Policies and procedures outlining how UKHSA complies with the Code of Practice for Statistics.

The UK Health Security Agency (UKHSA) monitors and reports on the health effects of fluoride for people living in areas covered by water fluoridation schemes.

Information about the group B meningococcal disease outbreak investigation survey.

Guidance on managing and preventing the spread of group A streptococcal (GAS) infection and other skin and soft tissue infections in prisons and secure settings.

Reports on travel-associated infections in England, Wales and Northern Ireland, based on data from national reference laboratories or case management systems.

Cumulative data showing the number of GP-registered patients in England having the seasonal influenza vaccine.

List of those receiving pre-release access to the monthly seasonal influenza vaccine uptake in GP patients.

Lists of those receiving pre-release access to UK Health Security Agency cover of vaccination evaluated rapidly (COVER) programme quarterly data

List of those receiving pre-release access to the monthly seasonal influenza vaccine uptake in healthcare workers.

Routine reports on confirmed cases of non-foodborne zoonoses reported in England.

Qualitative assessment of the risk that chikungunya virus presents to the UK population.

Data showing the number and proportion of frontline healthcare workers (HCWs) in England having seasonal influenza vaccines.

Analysis of data on non-travel associated shigella infections in England.

Resources to support health professionals with meningococcal outbreak response.

Information on the presentation, doses and storage of COVID-19 vaccines.

Addressing the increase in syphilis in England.

Supplementary data for the 2024 TB regional and devolved reports.

Annual regional reports for the epidemiology of TB in 2024.

Post-exposure prophylaxis (PEP) is offered to individuals at high risk of severe chickenpox following an exposure.

This rapid systematic review identified and summarised the viral load of people living with HIV on effective anti-retroviral treatment (ART)

Guidance for healthcare practitioners about the coronavirus (COVID-19) vaccination programme.

Coronavirus (COVID-19) vaccination information for public health professionals.

Synthesis of learning from a community pharmacy pilot

Haemophilus influenzae type b (Hib): immunisation information for public health professionals, including updates.

This rapid systematic review identified and summarised evidence of the effectiveness and cost effectiveness of intervention strategies to increase vaccine uptake.

Findings of the 2025 survey of women’s attitudes to vaccinations during pregnancy.

Easy read leaflet providing information on the shingles vaccine.

Outlines the scientific assets, capabilities and ambitions of UKHSA, and our plan to protect the nation’s health from current and future health threats.

The 2025 audit of the National Immunisation programme aligned with the UKHSA Immunisation Equity Strategy 2025 to 2030

The human T-cell lymphotropic virus (HTLV) National Register for blood donor screening and how to take part in research that helps improve understanding of HTLV.

How to avoid becoming unwell while visiting a farm.

Outlines the quality and methodology information (QMI) relevant to the respiratory syncytial virus (RSV) official statistics releases.

Immunisation information for health professionals and immunisation practitioners.

Cumulative vaccine uptake data for the childhood seasonal influenza programme in England, 2025 to 2026 data.

Rapid systematic review on effectiveness of additional IPC measures to precent spread of C. difficile in periods of high prevalence in health and social care settings.

A rapid systematic review on the effectiveness of isolation strategies for people with C. difficile.

Counts and rates of MRSA, MSSA, E. coli, P. aeruginosa, Klebsiella spp. bacteraemia and C. difficile infection (CDI) reported by independent sector healthcare organisations, with accompanying commentary. Official statistics in development.

Hepatitis B immunisation information for public health professionals.

Annual counts and rates of Escherichia coli (E. coli) bacteraemia by acute trust and sub-integrated care board location (SICBL).

Annual counts and rates of meticillin resistant Staphylococcus aureus (MRSA) bacteraemia by acute trust and sub-integrated care board location (SICBL).

Annual counts and rates of meticillin susceptible Staphylococcus aureus (MSSA) bacteraemia by acute trust and sub-integrated care board location (SICBL).

Trends in MRSA, MSSA, E. coli, Klebsiella spp. and P. aeruginosa bacteraemia and C. difficile infection by financial year.

Annual counts and rates of C. difficile infections (CDI) by acute trust and sub-integrated care board location (SICBL) in patients aged 2 years and over.

This annual report covers surgical site infection (SSI) data collected by NHS hospitals and independent sector NHS treatment centres.

Voluntary surveillance of streptococcal bacteraemia in England.

Trends in voluntary reports of Enterococcus spp. by age, sex and geographical distribution in England.

Reports presenting 30-day all-cause mortality following infection with healthcare-associated infections (HCAI).

Voluntary surveillance of paediatric bacteraemia in England.

Notifications of scarlet fever disease in England and data from invasive group A streptococci (iGAS) surveillance.

Annual reports and data tables showing the frequency of bloodstream infections in critical care units in England, the microbes that cause them, and linked factors.

Annual counts and rates of Pseudomonas aeruginosa (P. aeruginosa) bacteraemia by NHS acute trust and sub-integrated care board location (SICBL).

Annual counts and rates of Klebsiella species (Klebsiella spp.) bacteraemia by NHS acute trust and sub-integrated care board location (SICBL).

This rapid scoping review identifies and summarises existing UK guidance on healthcare provision at events.

This report describes the extent of infections and injecting-related harms among people who inject drugs (PWID) in the United Kingdom.

Lists of those receiving pre-release access to UK Health Security Agency cold mortality monitoring reports.

Annual report on the surveillance of mortality during cold episodes.

Outlines the quality and methodology information (QMI) relevant to the cold mortality monitoring reports.

Easy read guide providing information on the MMR vaccine.

TB is an infectious disease that usually affects the lungs. It can be serious, but it is treatable with antibiotics. Factsheet is translated into 32 languages.

Guidance to help public health professionals manage hepatitis A infections and recommendations for pre-exposure immunisation.

Joint annual report includes brief toxicological background to the Committees' decisions; discussion summaries; Committees' published statements.

Insights on the vaccine uptake and commentary on the RSV (respiratory syncytial virus) vaccination programme for older adults.

Reports presenting data for sexually transmitted infections (STIs) in the South West of England.

Insights on the vaccine uptake and commentary on the RSV (respiratory syncytial virus) vaccination programme for pregnant women.

Guidance for data managers and software providers on recording and reporting GUMCAD data.

This guidance is for health practitioners implementing the MMRV (measles, mumps, rubella and varicella) vaccination programme from 1 January 2026.

Guidance for clinical staff in specialist and non-specialist services commissioned to provide sexual health services in England.

A summary of safeguarding practices across the UK Health Security Agency (UKHSA).

UKHSA is working with the NHS to improve identification of sepsis in England. This study will help identify how many adults get sepsis in England and who is most affected.

Estimated annual deaths and hospitalisations prevented by routine childhood immunisation in England.

Effectiveness of contact tracing strategies for detection of Tuberculosis (TB) in people exposed to a person with active TB in low TB incidence countries.

MRSA, MSSA, Gram-negative bacteraemia infections by organisation and location of onset, and Clostridioides difficile infections (CDI) by organisation and prior trust exposure.

Quarterly reports for acute hepatitis B in England.

Public health evaluation of the opt-out BBV testing in EDs programme in England.

Report presenting data for sexually transmitted infections (STIs) in the East of England.

Information on the expansion of the eligibility criteria of the older adults respiratory syncytial virus (RSV) vaccination programme from 1 April 2026.

Documents relating to a chronic hepatitis B contact tracing pilot.

Details of UK Health Security Agency (UKHSA) transactions over £25,000 in 2025.

Reports presenting data for sexually transmitted infections (STIs) in the North West of England.

HPV vaccine coverage data for vaccinations in England, broken down by local authority, NHS commissioning region, integrated care board (ICB), sub-integrated care board (sub-ICB) and UKHSA region.

Vaccine coverage data estimates and commentary relating to the national Meningococcal ACWY (MenACWY) immunisation programme.

Annual reports from the national school leaver booster (tetanus, diphtheria and polio, Td/IPV) vaccination programme for adolescents.

Guidance for His Majesty’s Prisons (HMP) and non-HMP adult prison settings to prevent infection and reducing infection-related harms.

This framework outlines our commitment to ensuring that the conduct, management and communication of UKHSA's science and research activities are undertaken in ways that are trustworthy, ethical and responsible.

GP practices can send these template letters to parents to invite their child to routine vaccinations at their local surgery.

Summary of how to submit data to GUMCAD, the surveillance system for sexually transmitted infections, for all commissioned sexual health services in England.

Information about the UK’s progress towards measles and rubella elimination.

Guidance on how to manage influenza (flu) using anti-viral agents.

Advice on the use of sunbeds for cosmetic tanning: how to minimise exposure to ultraviolet radiation (UVR).

Guidance for health professionals on the incubation period, clinical features, sources and transmission of bacillus spp.

Outlines the quality and methodology information (QMI) relevant to the healthcare-associated infections (HCAI) accredited official statistics releases.

Details of UK Health Security Agency (UKHSA) Government Procurement Card (GPC) transactions over £500.

PGD template to support the national MMRV vaccination programme.

Report presenting data for sexually transmitted infections (STIs) in the North East of England.

Reports presenting annual epidemiological data for HIV in South West England.

Guidance for the public health management of avian influenza incidents, and sporadic human cases and their contacts.

A guide for parents and carers of children offered the MMRV vaccination which protects against measles, mumps, rubella and varicella.

Background and methodology for the 'Outbreaks under monitoring' report.

Guidance about infectious measles linked to international travel, including air, sea and land crossings

Reports presenting data since 2020 for sexually transmitted infections (STIs) in the Yorkshire and Humber region.

HIV testing surveillance data in England presented by all settings, demographic characteristics and geographical regions.

Reported cases of tetanus in England.

Monitors the number of people who visit their GP during surgery hours under the syndromic surveillance system.

The number of people going to emergency departments each day, with results published every week under the syndromic surveillance system.

This weekly summary highlights changes in the number of people visiting GPs, going to emergency departments and calling NHS 111.

The number of people contacting their GPs outside of surgery hours under the syndromic surveillance system.

Summary of the number of people calling NHS 111 for health advice within England on a weekly basis under the syndromic surveillance system.

The number of people calling ambulances each day, with results published every week under the syndromic surveillance system.

Weekly data from UK laboratories on the number of cases of notifiable bacteria and viruses (see important note in Details section, below).

Latest information on disease events under monitoring.

Reports presenting annual epidemiological data for HIV in East of England.

Laboratory confirmed cases of pertussis reported to the enhanced pertussis surveillance programme in England.

Results of laboratory-based surveillance of elevated blood lead concentrations in children in England.

A national public health bulletin from the UK Health Security Agency (UKHSA).

Data and analyses from UKHSA surveillance of chlamydia in England.

Data on trends in antimicrobial resistance and decreased susceptibility in gonococcal infection in England and Wales are provided by GRASP.

This statement provides the Committee on the Medical Effects of Air Pollutants’ response to the Air Quality Expert Group (AQEG) report on Indoor Air Quality.

Estimating health effects attributable to exposure to PM2.5 and NO2 indoors, using epidemiological studies on outdoor air pollution

These 8 rapid evidence summaries identified and summarised evidence on the key health topics in the event of a national power outage.

Information on the change of vaccine for the routine adult pneumococcal vaccination programme and individuals at increased clinical risk.

Estimates of the number and rates of people using opiates and/or crack cocaine in England between April 2022 and March 2023.

This plan outlines UKHSA's main deliverables and activities for the 2025 to 2026 financial year in support of the UKHSA strategic plan and remit letter.

Letter from Health Minister Ashley Dalton MP confirming the UK Health Security Agency’s role and priorities for the financial year 2025 to 2026.

UK Health Security Agency (UKHSA) annual report and accounts for the financial year 2024 to 2025, laid before Parliament on 11 December 2025.

Six-monthly epidemiological reports of Candidozyma auris in England.

Analysis of epidemiological reports of LGV infections in England (and the UK as a whole).

An examination of the epidemiology of syphilis in England presented by demographic characteristics to illustrate how different groups are affected.

Epidemiological, microbiological and food chain investigation summary about an outbreak of Shiga toxin-producing Escherichia coli (STEC).

This rapid systematic review aimed to identify and summarise evidence of routes of transmission of influenza A (H3N8, H5N2, H5N5, H5N6, H5N8, H7N9, H9N2, H10N3 and H10N5).

This rapid systematic review aimed to identify and summarise evidence of asymptomatic and pre-symptomatic transmission of influenza A (H3N8, H5N2, H5N5, H5N6, H5N8, H7N9, H9N2, H10N3 and H10N5).

This rapid systematic review identified and summarised evidence of the incubation and infectious period of influenza A (H3N8, H7N9, H9N2, H10N3 and H10N5).

We are seeking views on health and social care statistical outputs published by DHSC (including OHID), NHSBSA, UKHSA, ONS and NHS England.

An update on the November 2024 response to the consultation on health and social care statistical outputs which ran from December 2023 to March 2024.

This rapid evidence summary identified and summarised the evidence on the clinical and epidemiological features in people with conjunctivitis caused by influenza A (subtypes H5 or H7).

An evidence review of international and UK studies on the health impacts and benefits of transport interventions at schools.

This rapid evidence summary identified and summarised evidence relating to the infectious and incubation period of influenza (H5).

This rapid evidence summary identified and summarised evidence relating to the infectious and incubation period of influenza A (H5) in non-human mammals.

A rapid evidence summary identified and summarised evidence related to the incubation and infectious periods of influenza A (H1N1v and H1N2v).

A rapid evidence summary identifying and summarising evidence related to the infectious and incubation period, and pre-symptomatic and asymptomatic transmission of Influenza A (H1N1pdm09).

UKHSA hepatitis B virus reports and supporting documents for England.

Epidemiology of C. difficile RT955 infection in England between 2021 and 2025, with particular reference to an outbreak centred on the NHS Midlands region.

Laboratory-confirmed cases of hepatitis A.

Summaries of Mycoplasma pneumoniae infection reports from UKHSA and NHS laboratories in England and Wales.

The agenda and papers for the UK Health Security Agency (UKHSA) board meeting of 25 November 2025.

Reported cases of legionellosis in residents of England and Wales with onset of symptoms in 2024.

Effects of maternal exposure to ambient air pollution on adverse birth outcomes.

Outlines the quality and methodology information (QMI) relevant to Legionellosis in residents of England and Wales.

The climate change and mental health thematic assessment report synthesises the evidence base relating to climate change and mental health.

Laboratory-confirmed cases of invasive meningococcal disease reported to the enhanced meningococcal surveillance programme in England.

A rapid mapping review identifying and mapping evidence on the effectiveness and unintended consequences of public health and social measures (PHSM) when used for respiratory pathogens other than COVID-19.

A co-produced report to inform inclusion health action in health protection.

Introduction of a routine varicella vaccination programme for children at one year and at 18 months, with a catch-up for children aged up to 6 years

Estimates of the number and rates of people using opiates and/or crack cocaine in England between 2016 and 2020.

Technical assessments of the risk of mpox to the UK.

Qualitative assessment of the risk that Usutu virus presents to the UK population.

Reports presenting annual epidemiological data for HIV in north-east England.

Report setting out how UKHSA has responded to its equality duties.

Counts and rates of MRSA, MSSA, Gram-negative bacteraemia and C. difficile infections reported by independent sector organisations from April 2024 to March 2025.

A report summarising the work of the Committee on the Medical Effects of Air Pollutants (COMEAP) during 2024.

An assessment of evidence on the health effects of nano- and microplastic particles and fibres in the environment.

Laboratory-confirmed cases and notifications of rubella in England.

COMEAP’s updated views on the shape of the concentration-response curve linking fine particulate air pollution with mortality.

Laboratory-confirmed cases and notifications of mumps in England.

Official statistics annual data on coverage achieved by the childhood immunisation programme in England.

Reports summarising the activities of the UK's national reference laboratory (NRL) for food microbiology.

This document summarises national reference laboratory activities for April 2025 to March 2026.

UK quarterly data and commentary on coverage achieved by the UK childhood immunisation programme.

Evidence of the risk of human-to-animal transmission of Mycobacterium tuberculosis (TB).

Evidence of the risk of human-to-human transmission of Mycobacterium tuberculosis (TB).

Evidence of the risk of animal-to-human transmission of Mycobacterium tuberculosis (TB).

Evidence on the effect of antibiotics on morbidity and mortality in hospitalised patients with invasive PVL-SA infection.

The agenda and papers for the UK Health Security Agency (UKHSA) board meeting of 16 September 2025.

Supplementary data for the 2023 TB regional and devolved reports.

Annual regional reports for the epidemiology of TB in 2023.

A rapid systematic review of evidence on the effectiveness of communication strategies to deliver public health messages before, during and after CBRNe incidents and related civil events.

Annual reports from the national PPV immunisation programme for adults aged 65 years and over.

England annual data on coverage achieved by the childhood immunisation programme.

This letter sets out changes to the meningococcal C (MenC) vaccination schedule from 1 July 2016.

Use of intravenous immunoglobulin for the treatment of invasive PVL-SA infection in hospital inpatients.

Occurrence of venous thromboembolism in hospital inpatients with invasive PVL-SA infections.

Effectiveness of decolonisation regimes to prevent recurring or secondary infection with Staphylococcal skin and soft tissue infections.